Optimizing Outcome Prediction in Diffuse Large B-Cell Lymphoma by Use of Machine Learning and Nationwide Lymphoma Registries: A Nordic Lymphoma Group Study | JCO Clinical Cancer Informatics
The Enhanced International Prognostic Index for Diffuse Large B-cell Lymphoma
The Enhanced International Prognostic Index for Diffuse Large B‐cell Lymphoma | Semantic Scholar
Validation of the International Prognostic Index and Subsequent Revisions for Diffuse Large B-Cell Lymphoma in Patients From the
KoreaMed Synapse
NCCN-IPI score-independent prognostic potential of pretreatment uric acid levels for clinical outcome of diffuse large B-cell lymphoma patients | British Journal of Cancer
Five-year OS for low vs high NCCN-IPI risk groups (A) and according to... | Download Scientific Diagram
Videomed
Table 4 from An enhanced International Prognostic Index (NCCN-IPI) for patients with diffuse large B-cell lymphoma treated in the rituximab era. | Semantic Scholar
Table 2 from An enhanced International Prognostic Index (NCCN-IPI) for patients with diffuse large B-cell lymphoma treated in the rituximab era. | Semantic Scholar
Differential Impact of Relative Dose-Intensity Reductions in Diffuse Large B-Cell Lymphoma Treated with R-CHOP21 or R-CHOP14 | PLOS ONE
CT-Based Versus FDG-PET/CT–Based NCCN International Prognostic Index Risk Stratification in DLBCL in: Journal of the National Comprehensive Cancer Network Volume 13 Issue 2 (2015)
INDICE PRONOSTICO NCCN-IPI EN LINFOMA DIFUSO DE CELULA GRANDE (revisado 7-10-2014) - Linfomaymieloma.com
Validation of an enhanced International Prognostic Index (NCCN-IPI) in an Asian cohort of patients with diffuse large B cell lymphoma | SpringerLink
Is NCCN-IPI a Better Prognostic Tool for DLBCL Treated With R-CHOP?
Improving the Prognostic Index for Diffuse Large B-Cell Lymphoma
Table 3 from An enhanced International Prognostic Index (NCCN-IPI) for patients with diffuse large B-cell lymphoma treated in the rituximab era. | Semantic Scholar
Survival analysis according to NCCN-IPI (low NCCN-IPI score < 5 and... | Download Scientific Diagram
Table 1 from The revised International Prognostic Index (R-IPI) is a better predictor of outcome than the standard IPI for patients with diffuse large B-cell lymphoma treated with R-CHOP. | Semantic Scholar
Improving the Prognostic Index for Diffuse Large B-Cell Lymphoma
Interim 18F‑FDG PET/CT improves the prognostic value of S‑IPI, R‑IPI and NCCN‑IPI in patients with diffuse large B‑cell lymphoma
We applied the model of (A) NCCN-IPI in our study. Compared with (B)... | Download Scientific Diagram
Diffuse Large B-Cell Lymphoma: Can We Improve Our Current Approaches to Management?
Comparison of classic IPI, NCCN-IPI, and modified prognostic model for... | Download Table
xmlinkhub
Interim 18F‑FDG PET/CT improves the prognostic value of S‑IPI, R‑IPI and NCCN‑IPI in patients with diffuse large B‑cell lymphoma
The prognostic value of IPI in patients with primary breast lymphoma, a multicenter retrospective study | Cancer Cell International | Full Text
